Literature DB >> 12165109

Cardiovascular hemodynamics and exercise tolerance in thyroid disease.

George J Kahaly1, Christoph Kampmann, Susanne Mohr-Kahaly.   

Abstract

The heart is an organ sensitive to the action of thyroid hormone, and measurable changes in cardiovascular performance are detected with small variations in thyroid hormone serum concentrations. Most patients with thyroid disease experience cardiovascular manifestations, and the most serious complications of thyroid dysfunction occur as a result of cardiac involvement. The increased metabolic state and oxygen consumption that occur in hyperthyroid patients require an increased supply of oxygen and removal of metabolic products from the periphery. This is accomplished by increasing the cardiac output to meet the needs of the periphery. Circulation time is decreased in hyperthyroid patients, and a lowered arterial resistance and increased venous resistance promote the return of blood to the heart. Thyroid hormones may significantly decrease the strength of respiratory and skeletal muscles and affect regulatory mechanisms of adaptation to incremental effort. In hyperthyroidism, cardiovascular exercise testing and analysis of respiratory gas exchange demonstrate low efficiency of cardiopulmonary function as well as impaired chronotropic, contractile, and vasodilatatory reserves, which are reversible when euthyroidism is restored. During exercise, the increment (delta) of minute ventilation (respiratory rate x tidal volume), and oxygen pulse (oxygen uptake per heart beat) are significantly lower in dysthyroidism versus euthyroidism. Especially in older patients with thyroid dysfunction, markedly reduced workload, delta ejection fraction, and delta heart rate, both at the anaerobic threshold as well as at maximal exercise, are observed. In thyrotoxicosis, mitochondria oxidative dysfunction during exercise mostly causes intracellular acidosis, whereas in hypothyroidism, inadequate cardiovascular support appears to be one of the principal factors involved. These abnormalities partly explain why subjects with dysthyroidism are intolerant to exertion. Thus, in thyroid disease, both cardiac structures and function may remain normal at rest, however impaired cardiovascular and respiratory adaptation to effort becomes unmasked during exercise.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165109     DOI: 10.1089/105072502760143845

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  17 in total

Review 1.  Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment.

Authors:  Peter Laurberg; Stig Andersen; Inge Bülow Pedersen; Allan Carlé
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 2.  Cardiovascular involvement in patients with different causes of hyperthyroidism.

Authors:  Bernadette Biondi; George J Kahaly
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

Review 3.  The Unexplored Crossroads of the Female Athlete Triad and Iron Deficiency: A Narrative Review.

Authors:  Dylan L Petkus; Laura E Murray-Kolb; Mary Jane De Souza
Journal:  Sports Med       Date:  2017-09       Impact factor: 11.136

4.  Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism.

Authors:  Chung-Wah Siu; Chun-Yip Yeung; Chu-Pak Lau; Annie W C Kung; Hung-Fat Tse
Journal:  Heart       Date:  2006-09-27       Impact factor: 5.994

5.  Prevalence of echocardiographic criteria for the diagnosis of pulmonary hypertension in patients with Graves' disease: before and after antithyroid treatment.

Authors:  J H Suk; K I Cho; S H Lee; H G Lee; S M Kim; T I Kim; M K Kim; Y K Shong
Journal:  J Endocrinol Invest       Date:  2011-03-07       Impact factor: 4.256

6.  Effect of levothyroxine replacement on exercise performance in subclinical hypothyroidism.

Authors:  M R M Mainenti; P S Vigário; P F S Teixeira; M D L Maia; F P Oliveira; M Vaisman
Journal:  J Endocrinol Invest       Date:  2009-03-25       Impact factor: 4.256

Review 7.  Pheochromocytoma, thyroid disease, and hyperparathyroidism.

Authors:  Emanuel L Bravo
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-03       Impact factor: 3.738

8.  Thyroid hormone and cardiac disease: from basic concepts to clinical application.

Authors:  Iordanis Mourouzis; Francesca Forini; Constantinos Pantos; Giorgio Iervasi
Journal:  J Thyroid Res       Date:  2011-06-19

9.  Adenylyl Cyclase Type 5 Deficiency Protects Against Diet-Induced Obesity and Insulin Resistance.

Authors:  David Ho; Xin Zhao; Lin Yan; Chujun Yuan; Haihong Zong; Dorothy E Vatner; Jeffery E Pessin; Stephen F Vatner
Journal:  Diabetes       Date:  2015-03-02       Impact factor: 9.461

10.  Thyroid hormone levels in apparently euthyroid subjects with essential hypertension in a tertiary hospital in Nigeria.

Authors:  Abiodun Mathias Emokpae; Aliyu Abdu; Humphrey Benedo Osadolor
Journal:  J Lab Physicians       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.